Using digital tools is key to providing optimal care for a large — and growing — heart failure patient population, according DCRI Executive Director, Adrian Hernandez, MD, MHS at #ESCCongress. To do this, clinicians should: • build better systems and automate • leverage tools for patient engagement and automation • continuously evaluate new tools #digitalhealth #cardiology #heartfailure
Duke Clinical Research Institute
Research Services
Durham, North Carolina 18,612 followers
Developing & sharing knowledge that improves health around the world through innovative clinical research.
About us
As part of the Duke University School of Medicine, the Duke Clinical Research Institute (DCRI) is known globally for conducting groundbreaking multinational trials, managing major national patient registries, and performing landmark research. As an academic clinical research organization, we combine the faculty expertise of practicing physicians with the full-service operational capabilities of a major CRO. We design and implement innovative clinical trials that advance the understanding of health and disease and inform efforts to improve the quality of care. Our experience stretches from phase I to phase IV and beyond, encompassing post-approval analyses and health economics. The breadth of our work in numerous therapeutic areas is matched by the depth of our knowledge, which we disseminate through high-impact publications and global meetings. Since 1996, DCRI's faculty and staff have disseminated over 17,500 peer-reviewed publications and have been cited in over 760,500 scientific articles.
- Website
-
https://dcri.org
External link for Duke Clinical Research Institute
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Durham, North Carolina
- Type
- Educational
- Founded
- 1969
Locations
-
Primary
300 W Morgan St
Durham, North Carolina 27701, US
Employees at Duke Clinical Research Institute
Updates
-
Earlier today at #ESCCongress, DCRI's Renato Lopes, M.D., Ph.D, lead author of GUARD-AF, presented the results of the study. “Atrial fibrillation is often undiagnosed and can increase the risk of ischemic stroke, which is largely reversible by oral anticoagulation,” said Dr. Lopes in a press release for Duke Health. “We still need definitive evidence that diagnosis of atrial fibrillation through systematic screening can lead to subsequent treatment with oral anticoagulation and therefore, lower stroke risk.” Read the full release here: https://lnkd.in/ez4SJkdY #cardiology #stroke #AFib
-
-
The final day of #ESCCongress is tomorrow! Catch our DCRI faculty and fellows presenting at these sessions.
-
Asundexian once daily was shown to be inferior to apixaban in preventing stroke and systemic embolism for patients with #AFib at high risk for stroke, according to results from the OCEANIC-AF trial presented by Manesh Patel, MD at #ESCCongress. “Over 14,810 patients with atrial fibrillation at risk for stroke were enrolled over 11 months worldwide. Asundexian 50mg once daily was inferior for the prevention of stroke and systemic embolism compared with apixaban in patients with atrial fibrillation at high risk for stroke...Clearly more research is needed to determine if there is the correct amount of Factor XI inhibition for this indication, atrial fibrillation and stroke prevention.” View the presentation slides: https://lnkd.in/epQYpYbm View the paper in the NEJM: https://lnkd.in/eyDRpZj2 #cardiology #stroke
-
-
“In patients with a history of atrial fibrillation, the Apple Watch IRN is most sensitive at the individual level. It is less sensitive at the episode level. The current IRN algorithm for the Apple Watch favors long episodes greater than six hours. Thus, the limited sensitivity, the user independence, the limited accuracy of the IRN algorithm invites caution when we’re interpreting those data to make clinical decisions for our patients with known atrial fibrillation.” -DCRI faculty Jonathan Piccini, MD, MHS at #ESCCongress 2024 on how well Apple Watches performed at detecting #AFib in a known patient population. #cardiology #hearthealth
-
-
Following presenters at #ESCCongress yesterday who discussed the training requirements for European physicians and allied health professionals, DCRI’s Sana Al-Khatib, MD, MHS shared the American training requirements, ultimately concluding that they were fairly similar. “There’s one point that all of us can agree on: that’s basically that clinicians — either medical doctors or allied professionals should be competent enough to take care of patients,” Al-Khatib said. “So that’s why you have all these certification and recertification efforts...I think that it is incredibly important for us as a scientific community to test the impact of all these certification or recertification tools or exams. Not every person who aces a test is a very competent clinician." #clincialcare #patientcare #clinicians
-
-
Day two of #ESCCongress is over, and we’re ready for day three! Don’t miss out on these sessions with our DCRI faculty. #clinicaltrials #clinicalresearch #cardiology
-
During the Friday afternoon session “Delivering optimal care for patients with obesity during cardiac procedures” at #ESCCongress 2024, DCRI faculty member Jennifer Rymer, MD, MBA led a discussion about minimizing risk during procedures for both patients with obesity and the health providers who perform the procedures. “There’s really significant orthopedic and occupational risk for doing procedures in these patients — more difficult access, more difficult for the operator to position the patient, and there’s way more radiation exposure, which is huge,” said Dr. Rymer, following the session. “As your radiation creeps up, you can’t do everything you need to do in the procedure, because you can’t go over a certain radiation.” #obesity #patientcare #cardiology
-
-
The first day of #ESCCongress is in the books, and we’re gearing up for day two! Get the rundown on the upcoming sessions featuring DCRI faculty and fellows below. #clinicaltrials #clinicalresearch #cardiology
-
Tomorrow is the start of #ESCCongress 2024! Check out the sessions featuring presentations and contributions from DCRI faculty and fellows, and stay tuned to our page for more session and conference updates. #clinicaltrials #clinicalresearch #cardiology